ADVERTISEMENT

Conference Report

ASCO 2022 – Same neuroblastoma and treatment but different outcomes

Elena Riboldi — Agenzia Zoe   |   09 June 2022

Takeaway

  • Overall survival (OS) of children with high risk neuroblastoma (HR NBL) is affected by race/ethnicity and poverty despite access to upfront clinical trials.
  • More research is needed to individuate mechanisms linking ethnicity and socioeconomic status to outcomes in HR NBL.

 

Why this matters

  • Knowledge of inequity factors can...

          

November Challenge

Ends in 1d 6h
left
right

Topic Challenges

left
right